Rifaximin

Routes
Oral (PO)
Half-Life (t½)
PO: 6h
Formula
C43H51N3O11
Molecular Weight
785.88 g/mol
PubChem CID
6436173
Aliases
Xifaxan

Pharmacological Mechanism

Non-absorbed rifamycin — minimal systemic exposure (<1% bioavailability) means minimal CYP induction despite same PXR mechanism. Used for travelers diarrhea, hepatic encephalopathy (gut ammonia), and IBS-D (gut microbiome modulation).

Half-Life & Elimination Curve (PO: 6h)

100%50%25%12.5%0%0h0×t½6h1×t½12h2×t½18h3×t½24h4×t½30h5×t½0×t½ (0h): 100% remaining1×t½ (6h): 50% remaining2×t½ (12h): 25% remaining3×t½ (18h): 12.5% remaining4×t½ (24h): 6.3% remaining5×t½ (30h): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½6h50%
  • 2×t½12h25%
  • 3×t½18h12.5%
  • 4×t½24h6.3%
  • 5×t½30h3.1%
Elimination t½6h (PO)
Rate Constant (ke)0.116 h⁻¹
97% Washout (5×t½)30h

Dosing Guidelines

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers